Beijing Wantai Biological Pharmacy Enterprise Co Ltd Class A 603392
About Quantitative Ratings
Morningstar Quantitative Ratings for Stocks are generated using an algorithm that compares companies that are not under analyst coverage to peer companies that do receive analyst-driven ratings. Companies with quantitative ratings are not formally covered by a Morningstar analyst, but are statistically matched to analyst-rated companies, allowing our models to calculate a quantitative moat, fair value, and uncertainty rating.
Trading Information
- Previous Close Price
- ¥73.04
- Day Range
- ¥73.00–75.35
- 52-Week Range
- ¥40.14–88.00
- Bid/Ask
- ¥74.86 / ¥74.87
- Market Cap
- ¥94.72 Bil
- Volume/Avg
- 4.2 Mil / 3.0 Mil
Key Statistics
- Price/Earnings (Normalized)
- 85.49
- Price/Sales
- 34.36
- Dividend Yield (Trailing)
- 0.43%
- Dividend Yield (Forward)
- 0.43%
- Total Yield
- 0.43%
Company Profile
Beijing Wantai Biological Pharmacy Enterprise Co Ltd is engaged in Research, development, production and sales of in vitro diagnostic reagents, instruments and vaccines.
- Sector
- Healthcare
- Industry
- Biotechnology
- Stock Style Box
- Large Core
- Total Number of Employees
- 3,710
- Website
- http://www.ystwt.com
Comparables
Valuation
|
Metric
|
603392
|
688253
|
688068
|
|---|---|---|---|
Price/Earnings (Normalized) | 85.49 | 19.62 | — |
Price/Book Value | 7.57 | 2.70 | 0.77 |
Price/Sales | 34.36 | 8.00 | 4.95 |
Price/Cash Flow | 402.76 | 15.34 | — |
Price/Earnings
603392
688253
688068
Financial Strength
|
Metric
|
603392
|
688253
|
688068
|
|---|---|---|---|
Quick Ratio | 3.81 | 15.40 | 3.29 |
Current Ratio | 4.48 | 15.84 | 6.88 |
Interest Coverage | −59.06 | 2,238.82 | −253.76 |
Quick Ratio
603392
688253
688068
Profitability
|
Metric
|
603392
|
688253
|
688068
|
|---|---|---|---|
Return on Assets (Normalized) | −3.06% | 12.17% | −5.33% |
Return on Equity (Normalized) | −3.76% | 13.13% | −5.67% |
Return on Invested Capital (Normalized) | −4.05% | 12.68% | −6.61% |
Return on Assets
603392
688253
688068
Biotechnology Industry Comparables
|
1-Day Chart
|
Name
|
Price
|
Morningstar Rating for Stocks
|
Capital Allocation
|
Economic Moat
|
Market Cap
|
|---|---|---|---|---|---|---|
| Novo Nordisk AS ADR
NVO
| Zdggzqylxv | Nztc | $531.4 Bil | |||
| Vertex Pharmaceuticals Inc
VRTX
| Qcmrsxx | Hmlss | $119.5 Bil | |||
| Regeneron Pharmaceuticals Inc
REGN
| Jwnbxzht | Gptvs | $114.9 Bil | |||
| Alnylam Pharmaceuticals Inc
ALNY
| Njsffpyv | Fsqzdqb | $35.3 Bil | |||
| argenx SE ADR
ARGX
| Ftvmlmpss | Hfzth | $32.0 Bil | |||
| BioNTech SE ADR
BNTX
| Fyzfxtsz | Vhk | $28.1 Bil | |||
| Moderna Inc
MRNA
| Shbhwkthl | Blmz | $25.3 Bil | |||
| United Therapeutics Corp
UTHR
| Nrnpjyqt | Cfx | $16.0 Bil | |||
| Biomarin Pharmaceutical Inc
BMRN
| Xbkbbvlq | Xnpvxhy | $13.4 Bil | |||
| Incyte Corp
INCY
| Ssjxqkfc | Thbfn | $12.7 Bil |
United States